US Activist Hedge Fund Institutional SEC 13D 13G — October 26, 2026

26-10-2026

ARCH Venture Fund XII, L.P. and affiliated reporting persons filed a Schedule 13D disclosing beneficial ownership of 13,692,507 shares of City Therapeutics, Inc. common stock, equal to 25.6% of the 53,387,834 shares outstanding after the IPO. The position includes 2,027,006 shares bought in May 2026 at $13.3201 per share (Series B Preferred, converted to common at the IPO) and 170,000 shares bought on October 19, 2026 at $18.00 per share from the IPO underwriters, with total consideration for the purchases of $30,059,985.76. The shares are held for investment purposes, and the holders are subject to a 180-day lock-up expiring after October 15, 2026.

• · The reporting persons disclaim beneficial ownership of shares except those held of record by each person individually.
• · Investor Rights Agreement registration rights (demand, piggyback, shelf) terminate on the earliest of a Deemed Liquidation Event, the fifth anniversary of the IPO, or when Rule 144 permits sale of all shares without limitation in a three-month period.
• · Financial statement delivery, inspection, observer rights, and rights of first offer under the Investor Rights Agreement were terminated effective at IPO closing.
• · The reporting persons state no present plans relating to the matters in Item 4(a)-(j) of Schedule 13D, but may dispose of or acquire additional shares depending on market conditions.

26-10-2026

Abu Dhabi Investment Authority (ADIA), together with Platinum International Investment Holding RSC Limited and Platinum Falcon B 2018 RSC Limited, filed a Schedule 13G reporting beneficial ownership of 35,732,138 shares of Jersey Mike's Subs Inc. Class A Common Stock, equal to 15.3% of the 233,405,414 Class A shares outstanding as of September 4, 2026. The shares are held directly by Boardwalk II Aggregator L.P., with Platinum Falcon as the entity sharing dispositive power and ADIA as the ultimate owner through Platinum Holdings. The filing is a passive Rule 13d-1(d) disclosure with no reported sole voting or dispositive power.

• · Filing type is a Schedule 13G under Rule 13d-1(d), indicating a passive holder (typically a pre-IPO or exempt investor) rather than an activist filing under 13D
• · Reporting persons hold shared voting and dispositive power over all 35,732,138 shares; no sole power is reported
• · Ownership is held through a chain: ADIA owns Platinum Holdings, which solely owns Platinum Falcon, which may share power over shares held by Boardwalk II Aggregator L.P.
• · Event date (ownership measurement date) is September 30, 2026; filing date is October 26, 2026
• · Jersey Mike's Subs Inc. is registered in Delaware, with a Tinton Falls, NJ business address; SIC code 5812 (Retail-Eating Places)

26-10-2026

Hennessy Capital Investment Corp. VII's sponsor group, filing jointly on a Schedule 13G/A for ONE Nuclear Energy Inc. (formerly Hennessy Capital Investment Corp. VII, ticker HVIIU), reports beneficial ownership as of September 30, 2026. HC VII Sponsor LLC holds 5,744,999 shares (5.3% of 108,258,979 shares outstanding), with Hennessy Capital Group LLC and Daniel J. Hennessy deemed beneficial owners of the same block. Thomas D. Hennessy is reported at 6,494,999 shares (6.0%), including 750,000 shares he holds directly, and the filing is made under Rule 13d-1(d), indicating a passive, pre-existing holder rather than an active acquirer.

• · Filing made under Rule 13d-1(d), indicating a passive holder not subject to the 13D control-intent regime
• · Reporting persons' ownership is reported with no sole voting or dispositive power for the sponsor entities; shared power over the 5,744,999-share block
• · Thomas D. Hennessy is the only reporting person with sole voting and dispositive power (750,000 shares)
• · Filing reflects a name change from Hennessy Capital Investment Corp. VII to ONE Nuclear Energy Inc.; the SPAC sponsor entity remains the holder of record
• · Filing is an amendment (13G/A), updating a previously filed Schedule 13G position

26-10-2026

Trium Capital LLP filed Amendment No. 1 to its Schedule 13G (Rule 13d-1(b), institutional investor) reporting that, as of 08/19/2026, it beneficially owns 0 shares of RE/MAX Holdings, Inc. Class A Common Stock, representing 0.0% of the class. The filing indicates Trium has exited its previously reported passive stake, with all sole and shared voting and dispositive power reported as zero.

• · Filing reports 0 shares, 0.0% of class, with zero sole/shared voting and dispositive power, indicating a full exit from the position
• · Filed under Rule 13d-1(b) as an investment adviser (IA), certifying holdings were in the ordinary course of business and not for control purposes
• · Trium Capital LLP is a London-based investment adviser at 60 Gresham Street, London
• · Filing reference is an amendment (SCHEDULE 13G/A) with a 'LIVE' filing status, and the event date stated is 08/19/2026 while the filing date is 10/26/2026

26-10-2026

Amundi and Amundi Asset Management filed an amended Schedule 13G reporting beneficial ownership of 272,191,463 Orange S.A. shares, representing 10.23% of the class, as of 09/30/2026. Of this, Amundi holds sole dispositive power over 196,917,401 shares, while 75,274,062 shares are held with shared dispositive power, and neither entity has voting power over the roughly 191.9 million shares held through the employee FCPE. The filing is a routine ownership disclosure with no described control intent or transaction.

• · Filing is classified under Rule 13d-1(b) and reported by a holding company (HC) on a LIVE basis
• · Amundi disclaims voting rights over shares held in the Orange employee FCPE, which are voted by the FCPE supervisory board dominated by employee representatives
• · Amundi certifies the holdings were acquired and are held in the ordinary course of business without intent to change or influence control of Orange

26-10-2026

Amundi and its subsidiary Amundi Asset Management filed a Schedule 13G reporting beneficial ownership of 1,348,930 shares of Liberty Live Holdings, Inc. Series A Liberty Live Group common stock (LLYVB) as of September 30, 2026, representing 5.27% of the class. The filing is a passive institutional disclosure under Rule 13d-1(b) with no indication of control intent, and reports sole voting power over 35,211 shares and shared dispositive power over 1,313,719 shares.

• · Filing is a Schedule 13G under Rule 13d-1(b), certifying the shares were acquired in the ordinary course of business and not for the purpose of influencing control.
• · Both Amundi and Amundi Asset Management are organized under French law and are based in Paris, France.
• · Filing was signed by John M. Malone, Chief Compliance Officer, under power of attorney on 10/26/2026.

26-10-2026

Amundi and its subsidiary Amundi Asset Management filed an amended Schedule 13G reporting beneficial ownership of 3,291,588 Common Shares of California Water Service Group (CWT), representing 5.32% of the class as of 09/30/2026. The filing reports sole voting power over 1,775,076 shares and shared dispositive power over 1,516,512 shares, and is made under Rule 13d-1(b) as a passive holding in the ordinary course of business. No change in control intent is asserted.

• · Filing is an amendment (SCHEDULE 13G/A) reporting holdings as of 09/30/2026 and filed 10/26/2026
• · Reporting persons are classified as holding companies (HC) and file under Rule 13d-1(b), an institutional investor certification
• · Subsidiary KBI Global Investors entities are identified as sub-advisers or affiliates within the reporting group

26-10-2026

Amundi and its subsidiary Amundi Asset Management filed an amended Schedule 13G reporting beneficial ownership of 3,588,117 shares of Energy Recovery, Inc. (ERII) common stock, representing 7.03% of the class as of September 30, 2026. The filing reports 2,060,091 shares with shared voting power and 1,528,026 shares with shared dispositive power, and is filed under Rule 13d-1(b) as a passive institutional holding by a parent holding company (HC).

• · Filing is a Schedule 13G/A amendment (accession 0001172661-26-004697) filed October 26, 2026 under Rule 13d-1(b) by an institutional investor, indicating a passive rather than activist stake.
• · Amundi's beneficial ownership is held through subsidiaries including KBI Global Investors (North America) Ltd and KBI Global Investors Ltd, which are disclosed as entities through which holdings are aggregated.
• · Sole voting and sole dispositive power are reported as 0; all reported holdings are shared, consistent with managed-fund aggregation.
• · The filing references a prior LIVE 13G/A (accession 0001172661-26-002729) with a 09/30/2026 event date, indicating this is a subsequent amendment reflecting a change in the reported position.

26-10-2026

Lawrence B. Seidman and affiliated entities (collectively the Reporting Persons) amended their Schedule 13D to disclose beneficial ownership of 152,397 shares of URSB Bancorp, Inc. common stock, approximately 6.53% of the 2,334,375 shares outstanding as of June 30, 2026. All reported purchases occurred on October 22, 2026 in open-market transactions at prices between $13.10 and $13.14 per share, with an aggregate acquisition cost of approximately $1.71 million. Seidman and Veteri Place Corp. reported no purchases or sales during the period.

• · Purchases of approximately 6,538 shares in aggregate were executed on October 22, 2026 across six entities, all at prices between $13.10 and $13.14 per share
• · Veteri Place Corp and Lawrence B. Seidman did not purchase or sell any shares in the past sixty days
• · The filing amends a Schedule 13D previously filed September 23, 2026, and references a stake percentage calculated on the Issuer's June 30, 2026 share count
• · Holdings are reported as held with working capital, which may include margin loans from brokerage firms

26-10-2026

Mordecai Alfred Winborne filed a Schedule 13D reporting beneficial ownership of 50,000 shares of PRIMECAP Odyssey Discovery ETF (POMG), representing 6.58% of outstanding shares, acquired for approximately $1,274,608 in personal funds. The filing is stated to be for investment purposes only, with no intent to influence control, and the reporting person may buy or sell additional shares depending on price and liquidity.

• · Event date is 10/22/2026; filing dated October 26, 2026
• · Reporting person reports no shared voting or dispositive power; all 50,000 shares held with sole power
• · Reporting person has no contracts, arrangements, or pledges disclosed with respect to the securities (Items 4 and 6 reported as none/N/A)
• · Reporting person disclosed no criminal convictions or securities-law judgments in the last five years

26-10-2026

Amundi and its subsidiary Amundi Asset Management filed an amended Schedule 13G reporting beneficial ownership of 200,479,121 shares of TotalEnergies SE common stock, equal to 8.79% of the class, as of 09/30/2026. Amundi reports sole voting power over 52,869,112 shares and shared dispositive power over 147,610,009 shares, and disclaims voting rights over 141,036,858 shares held through employee FCPEs whose votes are exercised by their supervisory boards. The filing is made under Rule 13d-1(b) and is a routine passive-holder update with no change of control intent.

• · Filing is a Schedule 13G/A under Rule 13d-1(b), a passive institutional holder filing, with the cover page reflecting an event date of 09/30/2026.
• · Amundi certifies the shares were acquired and are held in the ordinary course of business without intent to change or influence control of TotalEnergies.
• · Filing references a prior accession number (0001172661-26-002732) in the primary document, while the header accession is 0001172661-26-004701; the holding date and percentage are as stated in the cover pages.

26-10-2026

Amundi filed a Schedule 13G/A reporting beneficial ownership of 68,832,052 Sanofi (SNYNF/SAN) shares, equal to 5.70% of the class, as of 09/30/2026. Of this total, Amundi reports sole voting power over 34,587,207 shares and sole dispositive power over 34,244,845 shares, with no shared voting or dispositive power. The filing is a routine passive-holder update under Rule 13d-1(b), with the holder certifying the shares were acquired in the ordinary course of business and not to influence control.

• · Amundi disclaims voting rights over 30,319,386 shares held through an employee FCPE; voting is exercised by the FCPE supervisory board, where employee representatives hold the majority
• · Filing covers multiple Amundi subsidiaries as reporting/affiliated persons, with the holding attributed to parent-level HC (holding company) status
• · Filing is categorized as Live (LIVE) with the subject security described as Common Stock / American Depositary Receipts / Convertible Bonds

26-10-2026

Perceptive Advisors LLC and affiliated reporting persons amended their Schedule 13D on LeonaBio, Inc. (formerly Athira Pharma, Inc.; the filing lists the subject company under its current name) to disclose that Perceptive Xontogeny Venture Fund II, LP received Sermonix pre-funded warrants exercisable for 2,352,932 shares of common stock on October 26, 2026, via a previously disclosed distribution of securities to Sermonix common stock holders. The warrants are subject to a 19.99% beneficial ownership blocker, and the aggregate reported position is 1,889,403 shares (19.99%) across the reporting group. The filing is a routine ownership update with no stated change in control intent.

• · Sermonix pre-funded warrants are exercisable only to the extent exercise would not push beneficial ownership above 19.99% of LeonaBio's outstanding common stock
• · Perceptive Xontogeny Venture Fund II, LP is the direct recipient of the warrants via the Sermonix distribution
• · Filing is labeled Schedule 13D/A (amendment 9), with event date 10/26/2026

26-10-2026

RA Capital Management, L.P., together with Peter Kolchinsky, Rajeev Shah and RA Capital Healthcare Fund, L.P., filed a Schedule 13G reporting beneficial ownership of 7,500,000 shares of Alector, Inc. common stock, representing 5.1% of the outstanding shares as of October 19, 2026. The filing is made under Rule 13d-1(c) as a passive investor, and the reporting persons certify the shares were not acquired to change or influence control of the issuer. The percentage is calculated on 111,656,919 shares outstanding as of July 31, 2026 plus 36,600,000 shares issued in an equity offering that closed October 19, 2026.

• · Filing made under Rule 13d-1(c), indicating a passive investor position rather than an activist 13D filing
• · Reporting persons disclaim group status and disclaim beneficial ownership beyond Section 13(d) obligations
• · The Fund has delegated sole voting and dispositive power to RA Capital and may not revoke on less than 61 days' notice
• · Filing reflects a dilution-driven shift: the 5.1% stake is measured against a share count enlarged by the October 2026 offering of 36.6 million shares

26-10-2026

TDR Capital-affiliated reporting persons filed Amendment No. 11 to Schedule 13D on Target Hospitality Corp. (TH), disclosing aggregate beneficial ownership of 14,303,619 shares (14.6% of 97,929,824 shares outstanding). The amendment was triggered by an in-kind distribution on October 22, 2026, in which Arrow Holdings and MFA Global transferred 1,922,744 shares of common stock to certain limited partners. The filing reports no change in the number of shares beneficially owned by the reporting group and no acquisition or disposition by the Reporting Persons as a whole.

• · The October 22, 2026 distribution in kind did not change aggregate beneficial ownership; the shares moved to limited partners of the holding entities, and the filing states no acquisition or disposition by the Reporting Persons.
• · The 14.6% figure is calculated on post-repurchase share count, reflecting the Issuer's stock buyback disclosed in its September 9, 2026 prospectus supplement.
• · The filing amends the prior Amendment No. 10 dated October 5, 2026, indicating an active series of ownership updates in a short period.
• · Each Reporting Person reports zero sole voting or dispositive power, with all 14,303,619 shares held under shared power.

26-10-2026

RA Capital Management, L.P., together with Peter Kolchinsky, Rajeev Shah, and RA Capital Healthcare Fund, L.P., filed a Schedule 13G on October 26, 2026 reporting beneficial ownership of 750,000 Class A ordinary shares of TCGX Acquisition Corp. II, equal to approximately 7.2% of the outstanding Class A shares. The filing is made under Rule 13d-1(c) as a passive investor, with the filers certifying the shares were not acquired to influence control of the issuer. The position is held directly by the Fund, with RA Capital acting as investment adviser and holding voting and dispositive power.

• · Event date of the reportable position is October 19, 2026, per the filing
• · Filers disclaim group status and disclaim beneficial ownership beyond Section 13(d) obligations
• · The Fund has delegated sole voting and dispositive power to RA Capital and may not revoke that delegation on less than 61 days' notice
• · Percentage is based on the issuer's final prospectus dated October 15, 2026, filed with the SEC on October 16, 2026
• · Filing is a joint filing under a Joint Filing Agreement (Exhibit 99.1) dated October 26, 2026

26-10-2026

American Airlines Group Inc. and its subsidiary American Airlines, Inc. filed a Schedule 13D reporting beneficial ownership of 31,838,775 common shares of Azul S.A. (7.9% of the 400,829,250 shares outstanding) following the exercise of warrants on October 20, 2026 for an aggregate cash exercise price of $100.0 million, funded from working capital. The filing states the reporting persons acquired the position in connection with the warrant exercise and intend to review their investment on a continuing basis, without any current plans described that would trigger the matters in Items 4(a)-(j).

• · Reporting persons have no current plans described under Items 4(a)-(j) but may engage management, the board, other securityholders, or explore extraordinary transactions such as mergers, security offerings, asset sales, or changes in board composition
• · Filing states no transactions in Common Shares were effected by the reporting persons in the past 60 days other than the warrant exercise described
• · No contracts, arrangements, or understandings with any person regarding Azul securities are disclosed, other than as set forth in the filing
• · Each ADS represents two Common Shares; the Common Shares themselves do not carry a separate CUSIP

26-10-2026

Global Value Investment Corporation (GVIC) and five affiliated reporting persons filed a Schedule 13D disclosing beneficial ownership of 1,251,627 shares of CPS Technologies Corp. (CPSH) common stock, representing approximately 6.46% of outstanding shares as of July 26, 2026. The filing reports purchases made for investment purposes at a total aggregate cost of approximately $4.33 million, with the reporting persons reserving the right to acquire additional shares or dispose of existing holdings. Most transactions in the 60-day window were open-market purchases at roughly $3.45–$3.50 per share, with a smaller set of purchases at $5.00 per share on October 16, 2026, and one reported sale of 3,995 shares by GVIC clients on October 14, 2026.

• · Transactions in the 60 days before filing were predominantly open-market purchases at weighted-average prices of roughly $3.45–$3.50 per share.
• · On October 16, 2026, GVIC, client accounts, Jeffrey Geygan, and James Geygan purchased a combined 14,500 shares at $5.00 per share, a premium to the other purchase prices in the window.
• · Largest single purchase in the window was 465,880 shares by GVIC clients on October 14, 2026 at $3.4741 per share.
• · Only reported sale in the window was 3,995 shares by GVIC clients on October 14, 2026 at $3.4999 per share; all other activity was purchases.
• · The filing states purchases were funded partly with investment capital and possibly margin borrowing, with pledged margin positions possible.
• · The reporting persons state the holdings are for investment purposes and disclaim beneficial ownership beyond their stated pecuniary interests; no control intent or plans under Item 4(a)-(j) are disclosed beyond ongoing monitoring and possible discussions with management or the Board.

26-10-2026

EEME Energy SPV I, LLC and its sole member Majique Ladnier amended their Schedule 13D to report beneficial ownership of 228,897,417.60 shares (38.3%) of XCF Global, Inc. common stock, with Ladnier reporting 270,564,515.60 shares (45.3%) including affiliated GL Part SPV entities. EEME acquired 119,397,858 shares on October 16, 2026 upon XCF's acquisition of Southern Energy Renewables, Inc. under the April 13, 2026 Business Combination Agreement, and is seeking up to $200 million in financing proposals for XCF while opposing a proposed reverse stock split. The filing signals intent to urge a foreign dual listing and, if a reverse split is deemed necessary to avoid Nasdaq delisting, to consider taking XCF private or trading on OTC Markets.

• · EEME is 6 months lock-up restricted from trading XCF shares issued under the BCA after closing, per the Company Support & Lock-Up Agreement dated April 13, 2026
• · EEME intends to vote against XCF's proposed reverse stock split, believing it unnecessary if XCF meets its 2027 projections
• · Potential lenders or investors providing the proposed financing could acquire some or all of EEME's XCF shares in the future
• · Shares were acquired via conversion of promissory notes, outright purchases funded by investor loans to EEME, and payment of an advisory fee
• · EEME is not soliciting proxies from shareholders on the reverse split or going-private/relisting proposals

26-10-2026

RBCH Ltd., together with its controlling individuals Viktor Fischer and Jakub Havrlant, filed Amendment No. 6 to Schedule 13D on Brera Holdings PLC (Nasdaq: SLMT), reporting beneficial ownership of 2,222,222 Class B Ordinary Shares (18.33% after warrant beneficial ownership limitation). The filing discloses the full exercise of pre-funded warrants and a public press release criticizing the company's H1 2026 results, including SOL per share dilution, cash burn, related-party compensation, and late filings. RBCH signaled continued discussions on board composition, a possible second extraordinary general meeting requisition, and unwinding of related-party share issuances.

• · RBCH Ltd. acquired 1,878,988 and 2,732,123 Class B shares (pre-reverse split) via pre-funded warrant exercises, funded from working capital.
• · Issuer executed a reverse share split effective May 14, 2026.
• · Viktor Fischer's unvested RSUs (4,444 pre-split) were forfeited on his resignation; 1,111 vested RSUs remain unsettled.
• · RBCH alleges the Issuer's public claim of zero-commission bare-metal UAE validators is misleading, as SOL is staked with Kraken at a 10% commission.
• · RBCH states the Issuer's late filings exposed it to roughly half its June 30 cash balance in liquidated damages and that related-party shareholders were not named.
• · RBCH previously requisitioned an extraordinary general meeting and is considering doing so again to replace Board members.

26-10-2026

Coastlands Capital LP and related reporting persons (including Matthew D. Perry) filed a Schedule 13G disclosing beneficial ownership of 1,355,119 shares of Kalaris Therapeutics, Inc. (KLRS) common stock, representing 5.69% of outstanding shares, based on 23,804,981 shares outstanding as of August 4, 2026. The filing is a passive, investment-only disclosure under Rule 13d-1 with reporting persons certifying the shares were not acquired to influence control; it contains no transaction, price, or amendment-of-control information.

• · Event date is 10/19/2026; filing made October 26, 2026 under Rule 13d-1(b) and 13d-1(c) (Live filing).
• · Reporting persons disclaim group membership and disclaim beneficial ownership beyond their pecuniary interest.
• · Shares are held for the benefit of the Partnership's investors, which has power to direct receipt of dividends or sale proceeds.
• · Sole voting and dispositive power is shared with reporting persons; sole power is reported as zero for all entities.
• · Former company names of the issuer include Allovir, Inc. and ViraCyte, Inc.; issuer is incorporated in Delaware, based in Berkeley Heights, NJ.

26-10-2026

Howard M. Lorber filed Amendment No. 15 to Schedule 13D reporting that the merger of Boardwalk Merger Sub Inc. into Nathan's Famous, Inc. closed on October 26, 2026, after which the company became a wholly-owned subsidiary of Smithfield Foods, Inc. Lorber's 989,841 beneficially owned shares and 20,000 restricted stock units were cashed out at $102.00 per share, and he now holds zero shares and has ceased to be a more-than-5% holder, making this an exit filing. The merger agreement was signed January 20, 2026, and the related Voting Agreement terminated at closing; the filing reports no balance-sheet or operating performance metrics, so no positive or negative period-over-period results are presented.

• · Merger closed October 26, 2026, with Nathan's Famous surviving as a wholly-owned subsidiary of Smithfield Foods
• · Voting Agreement signed January 20, 2026 terminated automatically at closing
• · Amendment No. 15 is the final amendment to the Schedule 13D and an exit filing

26-10-2026

AI DMI LLC, together with its controlling affiliates Access Industries Holdings LLC, Access Industries Management, LLC and Len Blavatnik, filed Amendment No. 7 to its Schedule 13D on Disc Medicine, Inc. (Nasdaq: IRON) reporting beneficial ownership of 2,943,410 shares of common stock (2,739,329 common shares plus 204,081 pre-funded warrants), or approximately 6.6% of the class. The filing states that the amendment reflects material changes since the prior Schedule 13D amendment and is based on 44,549,747 shares outstanding as of the Issuer's October 21, 2026 prospectus supplement. The filing does not disclose a purchase, sale, or deal terms in the extracted text, and the reporting persons disclaim beneficial ownership beyond their direct holdings.

• · Amendment No. 7 follows prior Schedule 13D amendments filed January 2023 through October 22, 2025, indicating a multi-year holding.
• · Ownership is held through a chain of control: Len Blavatnik controls Access Industries Management, which controls Access Industries Holdings, which indirectly controls AI DMI LLC.
• · Trade date referenced in the cover page is October 22, 2026; filing date is October 26, 2026.
• · The filing extract does not include a description of the transaction (purchase, sale, or distribution) in Item 4 or the new Item 5(c) transaction details, so the nature of the recent change cannot be confirmed from this text.

26-10-2026

Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander filed a Schedule 13G/A reporting beneficial ownership of 722,900 shares of Class A Common Stock of Lincoln International, Inc., representing 2.0% of the class as of September 30, 2026. The filing is a passive-investor disclosure made under Rule 13d-1(c), with a certification that the securities are not held to change or influence control of the issuer.

• · Filing is a Schedule 13G/A under Rule 13d-1(c), indicating a passive investor position rather than an activist filing
• · Reporting persons disclaim beneficial ownership of securities held by affiliated entities, per the footnote in Item 8
• · Joint filing agreement dated October 23, 2026 covers the three reporting persons (Exhibit I)
• · Position reported as of 09/30/2026 and the filing date is 10/26/2026; the filing is marked as a LIVE amendment

26-10-2026

PharmAla Biotech Holdings Inc. filed an amended Schedule 13G (Rule 13d-1(c), passive investor) reporting beneficial ownership of 132,867 shares of Jupiter Neurosciences, Inc. (JUNS) common stock as of September 30, 2026, equal to 10.1% of the 1,318,521 outstanding shares as of September 21, 2026. The filing reports sole voting and dispositive power over all 132,867 shares, with no shared power. The certification states the shares are not held to change or influence control of the issuer.

• · Filing is an amendment (LIVE) reporting a passive stake under Rule 13d-1(c), with a certification that the shares are not held to influence or change control of the issuer.
• · Accession number 0000912282-26-001297 is referenced in the primary document; the filing header lists accession 0000912282-26-001403, filed October 26, 2026. The signature is dated 10/21/2026.
• · PharmAla is a Toronto-based entity (Ontario, Canada) with CUSIP 48208B203 for the JUNS common stock (par value $0.0001).

26-10-2026

Millennium Management LLC, Millennium Group Management LLC, and Israel A. Englander filed a Schedule 13G/A reporting beneficial ownership of 4,686,105 shares of Apollo Commercial Real Estate Finance, Inc. (ARI) common stock as of September 30, 2026, representing approximately 3.6% of the class. The filing is a passive amendment under Rule 13d-1(c), with the reporting persons certifying the shares were not acquired to influence control of the issuer. No change in control intent or activist position is disclosed.

• · Filing is a Schedule 13G/A (amendment) filed under Rule 13d-1(c), indicating a passive investor status rather than a 13D activist filing
• · Sole voting power reported as 0; shared voting power and shared dispositive power each reported as 4,686,105 shares, with the shares held by entities under Millennium's voting control and investment discretion
• · Reporting persons disclaim beneficial ownership of securities held by affiliated entities except to the extent of pecuniary interest
• · Joint Filing Agreement dated October 23, 2026 among the three reporting persons under Rule 13d-1(k)

26-10-2026

Neil S. Subin, through MILFAM LLC, MILFAM GP, LLC, and Dark Mirage, LP, filed Amendment No. 2 to Schedule 13G reporting beneficial ownership of 21,777,316 Class A Common Shares of Optimum Communications, Inc. (OPTU), representing 13.3% of the Class A class as of an event date of 10/22/2026. The filing is a passive Rule 13d-1(c) disclosure, with the reporting persons certifying the shares were not acquired to influence control of the issuer.

• · Filing is Amendment No. 2 to Schedule 13G, filed under Rule 13d-1(c) as a passive investor
• · Dark Mirage, LP is the record holder; MILFAM LLC is its investment advisor and MILFAM GP, LLC its general partner
• · Reporting persons disclaim beneficial ownership beyond their pecuniary interest
• · Issuer is a cable and pay-TV services company (SIC 4841), headquartered in Long Island City, NY, formerly named Altice USA, Inc.
• · Other persons may have rights to receive dividends or sale proceeds from the shares held by Dark Mirage, LP

26-10-2026

Gravitas Collective Corp. filed a Schedule 13D reporting that on October 6, 2026 it received 25,000,000 shares of Hepion Pharmaceuticals, Inc. common stock in exchange for the membership interests of Gravitas Life Sciences, Inc., which it solely owned. The shares represent 19.9% of Hepion's 125,073,217 shares outstanding as of October 6, 2026, and were acquired for investment purposes. The filing discloses no negative or flat performance metrics, as it is a beneficial ownership disclosure rather than a financial results report.

• · Filing is a Schedule 13D (LIVE) for common stock, par value $0.0001 per share, of Hepion Pharmaceuticals, Inc. (formerly ContraVir Pharmaceuticals, Inc.)
• · Reporting person may make further acquisitions of Hepion common stock from time to time and states no current plans related to Item 4 matters, other than as described
• · Reporting person is a New Jersey-incorporated corporation with business address in Verona, NJ

26-10-2026

Justin LeBeau filed a Schedule 13D reporting beneficial ownership of 294,773 shares of SenesTech, Inc. common stock, or approximately 5.4% of outstanding shares (based on 5,423,542 shares outstanding as of August 4, 2026). The filer characterizes the stake as an investment in a stock he views as significantly undervalued, and he is urging capital discipline, reduced operating expenses, and an end to dilutive equity offerings. Purchases were made at prices between roughly $0.64 and $1.08 per share over the past 60 days, a period during which the stock traded lower.

• · The filer publicly agrees with views in a October 19, 2026 letter from Glenbrook Capital Management to the Chairman, including on minimizing equity dilution, expense discipline, performance-conditioned equity in lieu of cash compensation, and improved commercial and marketing execution, but states he is acting independently with no agreement with Glenbrook.
• · The filer states he may engage in discussions with management and the Board and may buy additional shares, sell some or all of his holding, or make proposals on the matters in Item 4(a) through (j).
• · Recent purchases were made at prices falling from about $1.08 (August 2026) to about $0.64 (October 2026), with the largest joint-account purchase of 95,911 shares on October 20, 2026 at a weighted average of $0.6893.
• · Shares are held in standard brokerage accounts that may be subject to margin terms.

26-10-2026

Mammoth Crest Capital LLC, together with Michael Hill (CEO/Chairman) and Barrett Evans (CFO/director), filed a joint Schedule 13D reporting beneficial ownership of 8,977,336 shares of APPlife Digital Solutions Inc (ALDS) common stock, or 60.3% of the class on an as-converted basis, which the filers may be deemed a group and may collectively control the Issuer. The filing also discloses insider-favorable arrangements: a proposed increase in authorized common stock from 20,000,000 to 990,000,000 shares, an extension of a SportsAlert note at 12% interest with a $2,750 extension fee, and accrued compensation owed to insiders (~$356,000 to Hill, ~$193,500 to Evans) and to MCC (~$910,000) that may be settled in securities. Percentages are highly sensitive to conversion assumptions, and excluding Series C Preferred conversion would reduce the group's stake to 39.2%.

• · Series C Preferred conversion is an estimate that drives most of the reported ownership; the stake falls from 60.3% to 39.2% without it.
• · Issuer has insufficient authorized, unreserved Common Stock to deliver all shares issuable on conversion.
• · Insiders and MCC are owed roughly $1.46 million in accrued compensation and loans that may be settled in Issuer securities, subject to Board approval.
• · SportsAlert note extension was approved with Hill abstaining, and the extension was not yet signed as of filing.
• · Shareholders holding ~77.56% of voting power approved the authorized share increase by written consent; effectiveness requires 20 days after definitive information statement mailing.
• · Insiders are two of three directors and, with MCC, may be deemed to control the Issuer.

26-10-2026

Xuewen Liu filed a Schedule 13G (Rule 13d-1(c)) disclosing that he crossed the 5% beneficial ownership threshold in Green Circle Decarbonize Technology Ltd (GCDT) on October 20, 2026 with 187,000 Class A Ordinary Shares (approximately 6.66%), peaked at 203,000 shares (approximately 7.24%), and disposed of his entire position through open-market sales on October 26, 2026, reporting 0 shares (0.0%) as of the filing date. The percentages are based on 2,805,867 Class A Ordinary Shares outstanding per the issuer's Form F-1 filed October 14, 2026. The filing reports a full exit, so no continuing stake or control intent is disclosed.

• · Filing made under Rule 13d-1(c), a passive investor designation, with the reporting person certifying no control intent
• · Filing reflects a full exit via open-market transactions within six days of crossing the 5% threshold
• · Reporting person's address is listed in Tucson, Arizona, while the issuer's business address is in Hong Kong
• · Filing is a LIVE (not amended) Schedule 13G, reported for an acquisition that exceeded 5% and was subsequently fully disposed of

26-10-2026

Monarch Alternative Capital LP and affiliated reporting persons filed Amendment No. 2 to their Schedule 13D on Capstone Energy+, Inc. (formerly Capstone Green Energy Holdings, CGEH), disclosing beneficial ownership of 19,333,334 shares (39.8%), comprising 3,333,334 common shares and 16,000,000 shares issuable on conversion of Series A Preferred Stock. The amendment reports that Brandon Schwertner was designated on October 23, 2026 as a Series A Director and approved by the Board on October 26, 2026, and that the Reporting Persons intend to discuss options for the forthcoming December 7, 2026 maturity of the Issuer's secured Notes, including possible refinancing and their potential participation, though no agreements or offers have been made.

• · Notes were issued under a Note Purchase Agreement dated December 7, 2023, between the Issuer's operating subsidiary and the purchasers party thereto
• · Reporting Persons have not reached any agreements or made any offers to the Issuer regarding the Notes as of the amendment date
• · Any definitive refinancing would require Board approval, Reporting Persons' investment committee processes, and required consents
• · Amendment No. 1 was filed June 29, 2026; the original Schedule 13D was filed April 3, 2026
• · Share count and ownership figures are unchanged from the initial Schedule 13D

26-10-2026

Royce & Associates LP filed an amended Schedule 13G reporting beneficial ownership of 675,579 shares of Luxfer Holdings PLC common stock, representing 2.50% of the outstanding class as of 09/30/2026. The filing reports sole voting and dispositive power over these shares, held on behalf of investment management clients, and is made under Rule 13d-1(d) with a certification that the holdings are in the ordinary course of business and not for the purpose of changing or influencing control. No change in control or transaction is described.

• · Filing is made under Rule 13d-1(d), indicating a passive investor exemption; the holder disclaims any pecuniary interest in the reported securities
• · Royce & Associates LP is an indirect majority-owned subsidiary of Franklin Resources, Inc.; the filing discloses information barriers separating it from other Franklin affiliates

26-10-2026

WBT Value Limited, a British Virgin Islands company, and its portfolio manager Roger Luo jointly filed a Schedule 13G reporting beneficial ownership of 6,201,167 Subordinate Voting Shares of Canada Goose Holdings Inc., representing approximately 13.29% of outstanding Subordinate Voting Shares. The filing is made under Rule 13d-1(c) as a passive investor and includes a certification that the shares were not acquired to change or influence control of the issuer.

• · Filing made under Rule 13d-1(c), indicating a passive investor certification rather than an active 13D filing
• · Shares are held entirely with sole voting and dispositive power (no shared power reported)
• · Filing reports the stake as of October 26, 2026, and is a joint filing with a Joint Filing Agreement (Exhibit I)
• · WBT Value Ltd was formerly named Fortune Enrichment Holdings Ltd, with the name change dated March 19, 2026

26-10-2026

Royce & Associates LP filed a Schedule 13G/A reporting beneficial ownership of 4,094,374 common shares of Major Drilling Group International Inc., representing approximately 4.98% of the outstanding shares as of September 30, 2026. The filing is made on a passive basis under Rule 13d-1(d), with RALP certifying the holdings were not acquired to influence control of the issuer. No change in control or transaction price is disclosed.

• · Holdings were reported as sole voting and sole dispositive power with no shared power.
• · Filing states RALP is an indirect majority-owned subsidiary of Franklin Resources, Inc. and disclaims beneficial ownership attributed to the Johnson principal shareholders.
• · Reporting is under Rule 13d-1(d), consistent with an exempt investor, and the holder certifies no control intent.

26-10-2026

Bain Capital-affiliated BCPE Seminole entities filed Amendment No. 11 to their Schedule 13D disclosing that Surgery Partners entered a Merger Agreement dated October 23, 2026 with Spyglass Topco, LLC, Spyglass Merger Subsidiary, Inc. and, for limited purposes, Bon Secours Mercy Health, Inc., under which the Issuer will become a wholly owned subsidiary of Parent. The Reporting Persons, which may be deemed to beneficially own 49,946,972 shares (approximately 38.15%), signed a Voting and Support Agreement to vote in favor of the merger and to roll over all their shares into Parent equity rather than receive the per-share merger consideration. The Reporting Persons made no transactions in the Common Stock during the past 60 days.

• · Reinvestment Stockholders will contribute all Rollover Shares to Parent (or a parent company) immediately before closing in exchange for Parent equity, and rollover shares will not receive the per-share merger consideration.
• · Rollover shares convert into Surviving Corporation common stock representing the same percentage ownership they held in the Issuer immediately before the merger.
• · Support Agreement is filed as Exhibit 13 (incorporated by reference to Exhibit 10.1 of the Issuer's 8-K filed October 26, 2026).
• · Ownership percentages are based on 130,918,260 shares outstanding as of August 3, 2026, per the Issuer's Form 10-Q filed August 10, 2026.
• · The filing reports no Reporting Person transactions in Common Stock in the past 60 days.

26-10-2026

Gil Shwed, co-founder and beneficial owner of CHECK POINT SOFTWARE TECHNOLOGIES LTD (CHKP), filed an amended Schedule 13G reporting beneficial ownership of 26,725,925 ordinary shares, representing 26.2% of the outstanding shares as of September 30, 2026. The position comprises 24,858,425 shares held directly (24.8% of outstanding) plus 1,867,500 shares issuable on options exercisable within 60 days. The filing is a routine beneficial ownership disclosure made under Rule 13d-1(d) and does not indicate a transaction, change of control, or new strategic action.

• · Filing made under Rule 13d-1(d), which applies to certain pre-IPO holders and exempt investors rather than active 13D filers
• · Reporting person holds sole voting and dispositive power over all 26,725,925 reported shares, with no shared power
• · Filing reflects holdings as of September 30, 2026, and is dated October 26, 2026
• · Issuer address listed as 5 Ha'Solelim Street, Tel Aviv, with the reporting person's contact address c/o the company's Shlomo Kaplan Street office

26-10-2026

Hosking Partners LLP filed an amended Schedule 13G reporting beneficial ownership of 8,374,924 shares of Ferroglobe PLC common stock, representing approximately 4.48% of the class as of 09/30/2026. The filer reports sole voting power over 1,359,030 shares and shared voting power over 8,374,924 shares, and classifies itself as an investment adviser (IA) filing under Rule 13d-1(b), certifying the holdings are not held to influence control of the issuer. This is a passive ownership disclosure with no reported change in control.

• · Filing is a Schedule 13G/A amendment with a stated event date of 09/30/2026, filed 10/26/2026
• · Filer is classified under Rule 13d-1(b) as an investment adviser, a passive institutional filing category
• · Reported ownership is roughly 4.5%, just below the 5% threshold that triggers mandatory 13G reporting for many filers

26-10-2026

Shikiar Asset Management, Inc. filed a Schedule 13G reporting beneficial ownership of 151,580 shares of FTAI Aviation Ltd.'s Series D Cumulative Perpetual Preferred Shares, representing 5.8% of the class as of September 30, 2026. The filing is made under Rule 13d-1(b) by an investment adviser (IA) and reports sole voting and dispositive power over all reported shares, with no shared power. No material change in the company's operations or financial position is disclosed.

• · Filing is made under Rule 13d-1(b) by an investment adviser; the filer certifies the holdings were acquired in the ordinary course of business and not for the purpose of influencing control of the issuer.
• · Event date of the holding is 09/30/2026; the filing itself is dated October 26, 2026.